Fundamental dimension Equity attribute | COTYLeader $3.23▲+0.62% Cap $2.84BP/E -4.6x QuantScore39/100 | AGROPeer $10.12▲+2.95% Cap $5.71BP/E 155.6x QuantScore33/100 | AKOPeer —— Cap —P/E 12.7x QuantScore— |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical Trend, RSI, MACD & signal consensus | |||
84/100 |
35/100 |
— |
Valuation Multiples, PEG & DCF upside | 60/100 | 21/100 | — |
Health Piotroski, Altman Z, leverage & liquidity | 16/100 | 28/100 | — |
Growth Revenue / earnings growth & margins | 18/100 | 25/100 | — |
Sentiment Analyst ratings, targets & revisions | 17/100 | 53/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -4.6x | 155.6x | 12.7x |
Forward P/E (next FY) | 10.0x | 6.6x | — |
EV / EBITDA (TTM) | 74.3x | 12.7x | 5.7x |
Price / Sales | 0.5x | 3.5x | 0.5x |
Price / Free Cash Flow | 8.2x | 119.6x | 6.6x |
PEG ratio | 0.10 | -0.12 | 0.04 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 5 / 9 | — |
Altman Z-Score | -0.20 (Distress) | 1.77 (Distress) | — |
Total debt / equity | 1.15 | 1.34 | 0.89 |
Quick ratio | 0.4x | 0.9x | 1.1x |
Interest coverage | 1.4x | 1.1x | 10.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -1.5% | -6.0% | — |
Net income growth YoY | -64.4% | -109.0% | — |
Gross margin (TTM) | 59.1% | 30.0% | 39.6% |
Operating margin (FY) | -1.4% | 4.7% | — |
FCF margin (FY) | 6.0% | 1.4% | — |
5. Trailing price performancePrice change over period |
1M return | +22.8% | -4.8% | — |
3M return | +21.9% | -4.3% | — |
6M return | +33.5% | -20.8% | — |
Year to date | +4.9% | +27.6% | — |
1Y return | -22.0% | +29.6% | — |
3Y return | -66.5% | -7.4% | — |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $10.95 +239.1% upside | $4.07 -59.8% premium | — — |
Wall Street consensus target | $2.86 -11.5% · range $2.60–$3.00 | $14.00 +38.3% · range $13.20–$14.80 | — — |
Consensus stance | 27% Buy64% Hold9% Sell | 38% Buy50% Hold13% Sell | — |